Identification of an additional lactate dehydrogenase isozyme band (LD-6) in 7 patients with severe congestive heart failure was associated with high mortality, with 3 patients dying within 3 weeks.
Case Report (n=7)
The presence of lactate dehydrogenase-6 (LD-6) may serve as a biochemical marker of serious hepatic circulatory disturbance in patients with severe congestive heart failure.
I confirmed the existence of an additional isozyme band of lactate dehydrogenase (LD) (EC 1.1.1.27) cathodic to LD-5 utilizing agarose gel isozyme electrophoresis in seven patients. Three of the patients died of circulatory failure within three weeks after the isozyme was identified. Four patients survived after successful therapy for heart failure. The under-lying clinical condition was arteriosclerotic cardiovascular disease causing congestive heart failure with passive congestion of the major viscera. I performed biochemical analysis on the isozyme and found that it was extremely heat stable, was not immunoglobulin bound, and contained only M, not H, subunits. It may represent a posttranslationally modified LD-5 or alcohol dehydrogenase.
Paul L. Wolf (Thu,) conducted a case report in Arteriosclerotic cardiovascular disease causing congestive heart failure with passive congestion of the major viscera (n=7). Lactate dehydrogenase-6 (LD-6) isozyme band was evaluated. Identification of an additional lactate dehydrogenase isozyme band (LD-6) in 7 patients with severe congestive heart failure was associated with high mortality, with 3 patients dying within 3 weeks.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: